Top Markets
Coin of the day
Abbott Laboratories Abbott Laboratories

Abbott Laboratories

ABT
Classifica tra le azioni #84
Abbott Laboratories, together with its subsidiaries, discovers, develops,... Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.
Prezzo delle azioni
$101.91
Capitalizzazione di mercato
$177.09B
Variazione (1 giorno)
-1.97%
Variazione (1 anno)
-19.78%
Paese
US
Scambia Abbott Laboratories (ABT)

Categoria

Utile per Abbott Laboratories (ABT)
Utile nel Dec 2025 TTM: $8.47B
Secondo gli ultimi rapporti finanziari di Abbott Laboratories, gli utili attuali della società sono $8.47B. Nel 2024, la società ha registrato un utile di $7.01B, un aumento rispetto a agli utili del 2023, che erano di $6.66B. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Storico degli utili di Abbott Laboratories dal 2000 al 2026
Utile alla fine di ogni anno
Anno Utile Cambia
2026 (TTM) $8.47B 0.00%
2025 $8.47B 20.72%
2024 $7.01B 5.24%
2023 $6.66B -19.77%
2022 $8.31B 1.16%
2021 $8.21B 65.28%
2020 $4.97B 21.85%
2019 $4.08B 41.91%
2018 $2.87B 28.78%
2017 $2.23B 57.89%
2016 $1.41B -55.61%
2015 $3.18B 26.41%
2014 $2.52B -0.12%
2013 $2.52B -59.75%
2012 $6.26B 20.47%
2011 $5.20B -9.00%
2010 $5.71B -20.59%
2009 $7.19B 22.84%
2008 $5.86B 31.02%
2007 $4.47B 96.35%
2006 $2.28B -50.73%
2005 $4.62B 11.98%
2004 $4.13B 10.48%
2003 $3.73B 1.66%
2002 $3.67B 95.07%
2001 $1.88B -50.66%
2000 $3.82B 0.00%
Utile per aziende simili o concorrenti
Azienda Utile Differenza negli utili Il paese
$4.51B -46.68%
US
$5.56B -34.27%
IE
$5.56B -34.29%
IE
$3.39B -60.02%
US
$3.13B -63.01%
DE